
| 2015 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2020 | 0 | 5.887.274 | 0 | 1 | ||
| 2015 | 0 | 26.193.660 | 438.500 | 2 | ||
Total number of partners: 78
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 78
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2020-01-01 | taRgeted thErapy for adVanced colorEctal canceR paTients | REVERT | participant | 5.887.274 | 23 |
| 2015-01-01 | TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development | TBVAC2020 | participant | 18.200.000 | 44 |
| 2015-01-01 | Eliciting Mucosal Immunity to Tuberculosis | EMI-TB | participant | 7.993.660 | 14 |